•  
  •  
  •  
  •  

2022-05-21 21:22:35

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Premco Global Ltd posts consolidated PAT of Rs. 2.25 crore in Q4FY22
  • Orbit Exports Ltd consolidated Q4FY22 net profit at Rs. 5.40 crores
  • Gulf Oil Lubricants India posts net profit of Rs. 63.39 crores in Q4FY22
  • Finance Minister announces reduction of Central Excise Duty on Petrol, Diesel
  • Redington India Ltd recommends dividend of Rs. 6.60

Keywords Selected:  Pharmaceuticals

Research

  • Quant Pick - Cadila Healthcare - ICICI Direct
  • Q2FY22 Result Update - Syngene International - ICICI Direct
  • Syngene International Ltd - Lack of near term triggers - YES Securities
  • Syngene International Ltd - Lower gross margin lead to EBIDTA miss - YES Securities

Stock Report

  • Glenmark Pharma gets 5 observations from U.S. FDA for its Goa, India Facility
  • Glenmark Pharma gets 17 observations from U.S. FDA for its Monroe, North Carolina (USA) Facility
  • Glenmark Pharmaceuticals receives ANDA approval for Abiraterone Acetate Tablets USP, 500 mg
  • Lincoln Pharmaceuticals Ltd recommends dividend of Rs. 1.50
  • Lincoln Pharmaceuticals Q4FY22 consolidated PAT falls to Rs. 11.02 crores
  • Fredun Pharmaceuticals Ltd Board recommends final dividend of Rs. 0.70
  • GlaxoSmithKline Pharmaceuticals Ltd recommends dividend of Rs. 90
  • Fredun Pharmaceuticals posts net profit of Rs. 2.29 crores in Q4FY22
  • GlaxoSmithKline Pharmaceuticals Ltd Q4FY22 consolidated profit at Rs. 1219.05 crores
  • Alembic Pharmaceuticals receives USFDA final approvl for Arformoterol Tartrate Inhalation Solution
  • Suven Pharmaceuticals Q4 FY2022 consolidated PAT slides QoQ to Rs. 91.66 crores
  • Suven Pharmaceuticals Limited declares 2nd interim dividend of Rs. 1
  • Glenmark Pharmaceuticals receives tentative ANDA approval for Calcipotriene and Betamethasone Dipropionate Foam, 0.005%, 0.064%
  • Aleor Dermaceuticals receives USFDA Final Approval for Docosanol Cream, 10% (OTC)
  • Alembic Pharmaceuticals Q4FY22 consolidated PAT declines to Rs. 35.46 crores
  • Alembic Pharmaceuticals Ltd Board recommends Dividend of Rs. 10
  • India Ratings Upgrades Torrent Pharmaceuticals and its NCDs to 'IND AA+', Outlook Stable
  • Glenmark receives the 'India Pharma Innovation of the Year' Award from the Government of India
  • Aleor Dermaceuticals Limited receives USFDA Final Approval for Clobetasol Propionate Foam, 0.05%
  • Glenmark to launch Drug for Type 2 Diabetes in India
  • IOL Chemicals and Pharmaceuticals Ltd commences commercial production of Paracetamol
  • Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg
  • Earum Pharmaceuticals Q4FY22 net loss at Rs. 71.60 lakhs
  • Aleor Dermaceuticals Limited receives USFDA Final Approval for Lidocaine and Prilocaine Cream USP, 2.5%/2.5%

Latest Post

  • Premco Global Ltd posts consolidated PAT of Rs. 2.25 crore in Q4FY22
  • Orbit Exports Ltd consolidated Q4FY22 net profit at Rs. 5.40 crores
  • Gulf Oil Lubricants India posts net profit of Rs. 63.39 crores in Q4FY22
  • Finance Minister announces reduction of Central Excise Duty on Petrol, Diesel
  • Redington India Ltd recommends dividend of Rs. 6.60


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
No:AP-172, 2nd Sector, 10th Street, KK Nagar
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-80560-88967
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

Disclaimer Copyright © - 2021